GLIMEPIRIDE

Tracking # 20-1060112

$99999.00

There are no ratings for this course

Learn more

Educator STATPEARLS PUBLISHING, LLC

CE Broker Reporting Reported automatically

Method Computer-Based Training

Course overview

GLIMEPIRIDE IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF TYPE 2 DIABETES MELLITUS. IT IS IN THE SULFONYLUREA CLASS OF DRUGS. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, AND CONTRAINDICATIONS FOR GLIMEPIRIDE AS A VALUABLE AGENT IN MANAGING TYPE 2 DIABETES MELLITUS. THIS ACTIVITY WILL ALSO HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., DOSING, PHARMACODYNAMICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR INTERPROFESSIONAL HEALTHCARE TEAM MEMBERS MANAGING PATIENTS WITH TYPE 2 DIABETES MELLITUS AND RELATED CONDITIONS.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I